Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Background
The frequency of “exhausted” or checkpoint-positive (PD-1
+
CTLA-4
+
) cytotoxic lymphocytes (Tex) in the tumor microenvironment is associated with response to anti-PD-1 therapy in metastatic melanoma. The current study determined whether pretreatment Tex cells in locally advanced melanoma predicted response to neoadjuvant...
Alternative Titles
Full title
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8317618
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8317618
Other Identifiers
ISSN
1068-9265
E-ISSN
1534-4681
DOI
10.1245/s10434-020-08648-7
